Arkray USA, Inc., of Edina, Minn., has been cleared by the FDA to market its Glucocard 01 Blood Glucose Monitoring System, which requires no coding, displays results in seven seconds, and requires a tiny 0.3-microliter sample size.
Glucocard has a 360-count test memory with time and date stamp, and was shown by clinical data to be highly accurate.
“The novel Glucocard 01 system follows the Glucocard brand image of sleek, compact, and discreet. Its appearance is similar to leading cell-phone designs and unlike other glucose monitors on the market,” said Arkray President Jonathan Chapman.
“We look forward to building off the Glucocard 01 technology and launching further systems later this year that will utilize the identical test strip.”